Insider · CIK 0001443841

Ciaffoni Joseph

Reports to the SEC for 4 companies · NORTH CHESTERFIELD, VA

sec.gov

Transactions

Companies

Filings

CIK

0001443841

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-22	INDVIndivior Pharmaceuticals, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−613K sh	$38.32	−$23.5M	790,330
2026-06-22	INDVIndivior Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1.27M sh	—	—	1,402,879
2026-06-22	INDVIndivior Pharmaceuticals, Inc. · Performance Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1.27M sh	—	—	0
2026-02-10	INDVIndivior Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+80K sh	—	—	135,976
2024-02-12	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director, President and CEO	AAward	+119K sh	—	—	394,000
2024-02-12	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	Director, President and CEO	FTax Payment	−81.4K sh	$33.70	−$2.74M	444,867
2024-02-12	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director, President and CEO	AAward	+180K sh	—	—	573,734
2024-02-12	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	Director, President and CEO	FTax Payment	−47.4K sh	$33.70	−$1.6M	526,289
2023-12-21	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−4,357 sh	$30.38	−$132K	275,000
2023-12-21	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+4,357 sh	$21.34	+$93K	279,357
2023-12-21	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−4,357 sh	—	—	16,875
2023-12-20	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+26.5K sh	$21.34	+$565K	301,454
2023-12-20	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−26.5K sh	—	—	21,232
2023-12-20	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−26.5K sh	$30.40	−$804K	275,000
2023-12-19	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.5K sh	$21.34	+$310K	289,516
2023-12-19	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−14.5K sh	$30.03	−$436K	275,000
2023-12-19	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.5K sh	—	—	47,686
2023-12-18	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−27.8K sh	$30.04	−$835K	275,000
2023-12-18	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+27.8K sh	$21.34	+$593K	302,798
2023-12-18	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−27.8K sh	—	—	62,202
2023-06-02	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−1,000 sh	$22.25	−$22.3K	275,000
2023-06-02	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−30.3K sh	$21.58	−$653K	276,000
2023-06-01	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−31.3K sh	$22.09	−$691K	306,272
2023-05-31	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−31.3K sh	$21.87	−$684K	337,544
2023-05-30	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−31.3K sh	$21.90	−$685K	368,816
2023-02-13	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.3K sh	$15.90	+$179K	411,337
2023-02-13	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−11.3K sh	$26.88	−$302K	400,087
2023-02-13	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−11.3K sh	—	—	0
2023-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director, President and CEO	AAward	+138K sh	—	—	503,944
2023-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director, President and CEO	AAward	+118K sh	—	—	366,250
2023-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	Director, President and CEO	FTax Payment	−59.7K sh	$26.75	−$1.6M	400,087
2023-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	Director, President and CEO	FTax Payment	−44.1K sh	$26.75	−$1.18M	459,823
2022-12-27	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−400 sh	$24.19	−$9,676	248,750
2022-12-27	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−1,804 sh	$23.65	−$42.7K	249,150
2022-12-23	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−147 sh	$23.00	−$3,381	250,954
2022-12-22	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−110 sh	$23.00	−$2,530	251,101
2022-12-21	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−7,333 sh	$23.11	−$169K	251,211
2022-12-20	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−9,375 sh	$23.07	−$216K	258,544
2022-12-19	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−1,134 sh	$23.01	−$26.1K	267,919
2022-12-02	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−54.4K sh	$23.07	−$1.26M	269,053
2022-12-01	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−76.7K sh	—	—	0
2022-12-01	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−76.7K sh	$22.47	−$1.72M	323,453
2022-12-01	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+76.7K sh	$15.90	+$1.22M	400,106
2022-11-28	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+43 sh	$15.90	+$683.7	323,496
2022-11-28	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−43 sh	$22.00	−$946	323,453
2022-11-28	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−43 sh	—	—	0
2022-11-22	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−65 sh	—	—	0
2022-11-22	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director, President and CEO	SSale	−65 sh	$22.00	−$1,430	323,453
2022-11-22	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+65 sh	$15.90	+$1,033.5	323,518
2022-11-18	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,989 sh	$15.90	+$31.6K	325,442

Recent filings

Accepted (ET)
Jun 234
Ciaffoni Joseph0001443841-26-000007
SEC(opens sec.gov)
Feb 124
Ciaffoni Joseph0001443841-26-000004
SEC(opens sec.gov)
Feb 144
Ciaffoni Joseph0001062993-24-003166
SEC(opens sec.gov)
Dec 224
Ciaffoni Joseph0001062993-23-023100
SEC(opens sec.gov)
Dec 204
Ciaffoni Joseph0001062993-23-022977
SEC(opens sec.gov)

Companies

Address

10710 MIDLOTHIAN TURNPIKE SUITE 125

NORTH CHESTERFIELD, VA, 23235